{
  "docId": "019de075-7539-774f-abd7-26734f481c17",
  "docSlug": "efb32a48c20b71d9dd70ea37e2f1bc4b",
  "documentTitle": "argenx SE | Investor Presentation Deck | 26 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 21,
  "pageCount": 26,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "other",
  "function": "establish_context",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Clinical trial design slide showing a timeline of visits and dosing phases.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-7539-774f-abd7-26734f481c17/21",
  "deckHref": "/decks/019de075-7539-774f-abd7-26734f481c17",
  "deckJsonHref": "/decks/019de075-7539-774f-abd7-26734f481c17.json",
  "deckAnchorHref": "/decks/019de075-7539-774f-abd7-26734f481c17#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.44,
        "x": 0.28,
        "y": 0.85
      },
      "kind": "callout",
      "text": "Topline data expected 4Q 2023",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "76990523-3779-41fb-839f-8dc9a9ae3377",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.928,
        "x": 0.036,
        "y": 0.245
      },
      "kind": "diagram",
      "text": "Trial timeline from week 0 to 24 with visit markers and dosing phases.",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bebd805b-46d0-418a-a2f1-5ccbc257a9d1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.08,
        "x": 0.89,
        "y": 0.91
      },
      "kind": "image",
      "text": "argenx logo",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "87ba09a1-0aba-40df-95df-68b2785ea038",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.928,
        "x": 0.036,
        "y": 0.7
      },
      "kind": "list",
      "text": "Primary endpoint: Sustained platelet count (≥50×10⁹/L) in ≥4/6 visits between weeks 19 and 24; Stringent endpoint in line with regulatory feedback; Secondary and exploratory endpoints centre around disease control.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "989db9f8-dce7-492d-8a9d-81dc0e1184af",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.095,
        "w": 0.327,
        "x": 0.036,
        "y": 0.045
      },
      "kind": "title",
      "text": "ITP ADVANCE-SC Trial",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e2db131-e15d-412d-8a4a-4b01b23c95dd",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 22,
      "from": 17,
      "beatId": "480800cd-70e9-4515-9ba7-53fd5332fee0",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Visualization",
      "beatSlug": "monroes-sequence-visualization",
      "evidence": "Slides 17-22 present various trials and studies, visualizing the company's progress.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}